540204 — Eiko Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeMicro CapNeutral

Annual balance sheet for Eiko Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	69.4	4.46	6.12	133	118
Net Total Accounts Receivable
Net Total Receivables	34.1	45.6	71.1	131	108
Total Inventory
Total Other Current Assets
Total Current Assets	107	124	93	309	329
Net Property, Plant And Equipment	2.48	143	139	136	231
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	166	349	310	527	661
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	39.6	60.1	12	15	62.7
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	40.9	62.6	16.2	20.6	93.1
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	125	286	294	507	568
Total Liabilities & Shareholders' Equity	166	349	310	527	661
Total Common Shares Outstanding